Linkage of DNA markers at Xq28 to adrenoleukodystrophy and adrenomyeloneuropathy present within the same family.

We present a large kindred that contained patients with either adrenoleukodystrophy (ALD) or adrenomyeloneuropathy (AMN). The pedigree clearly supported the X-linked mode of inheritance of the nonneonatal form of ALD/AMN. Analysis with DNA markers at Xq28 suggested segregation of both ALD and AMN with an identical haplotype. This indicated that nonneonatal ALD and AMN are caused by a mutation in the same gene at Xq28. It showed, furthermore, that phenotypic differences between ALD and AMN are not necessarily the consequence of allelic heterogeneity due to different mutations within the same gene. The maximal lod score for linkage of the ALD/AMN gene and the multiallelic anonymous DNA marker at DXS52 was 3.0 at a recombination fraction of 0.00. This made a prenatal or presymptomatic diagnosis and heterozygote detection by DNA analysis with this marker reliable.

In vitro expression of alpha-L-fucosidase activity polymorphism observed in plasma.

Several quantitative and qualitative characteristics of alpha-L-fucosidase were studied in cultured skin fibroblasts derived from variant and non-variant individuals. In comparison with non-variant cultures with similar growth characteristics, the intracellular level of alpha-L-fucosidase was specifically reduced by at least 50% at all stages of the culture cycle. The amount of enzyme released into the growth medium was also decreased, but the ratio of the extracellular enzyme to the total enzyme activity produced, was not significantly different from that in non-variant cultures. pH-dependence, apparent Km value and temperature sensitivity of the variant alpha-L-fucosidase were identical to that of the enzyme in non-variant cells. Specific differences between the variant and non-variant enzyme were consistently observed upon enzyme inactivation at acid pH and in thermostabilisation studies with NaCl. The DEAE elution profiles and pH-dependent association patterns obtained by ultracentrifugation were also different for both types of intracellular alpha-L-fucosidase. It is concluded that the quantitative as well as the qualitative differences of alpha-L-fucosidase characteristics found in variant fibroblasts are the in vitro expression of the variant genotype, already phenotypically observed in human plasma.

alpha-D-mannosidases in serum of patients with I-cell disease (ICD).

The specific activity of alpha-D-mannosidase in serum of ICD-patients is considerably increased due to increased amounts of the component with optimal activity at pH 4.6 (acidic form). The intermediate form with pH optimum of 6.0 remains unaltered. These conclusions were reached by using optimal conditions for differential assay of the alpha-D-mannosidases checked by partial separation of the components in serum by sucrose gradient centrifugation.

pH-dependent association-dissociation of high and low activity plasma alpha-L-fucosidase.

Population and family studies have confirmed the existence of a plasma alpha-L-fucosidase polymorphism in humans and the autosomal recessive inheritance of the low activity trait. The frequency of the latter is estimated at 11%. The low activity individuals or variants can also be distinguished by the fact that their plasma alpha-L-fucosidase is heat-inactivated at acidic pH. Sucrose gradient centrifugation results indicate the transition of non-variant plasma alpha-L-fucosidase with a molecular weight of 66,000 at pH 8.4 to an enzyme form with a molecular weight of 193,000 at pH 3.0. The former is thermolabile, the latter thermostable. Interconversion is pH-dependent. It is hypothesized that the non-variant enzyme, a monomer at alkaline pH, changes upon acidification into a trimeric conformation via dimerization. The thermolabile variant alpha-L-fucosidase monomer is not converted into a trimer, but only partially into a dimer.

Chromatographic components of beta-hexosaminidase in I-cell disease (mucolipidosis II).

Isozymes of N-acetyl-beta-D-hexosaminidase in body fluids, culture medium, postmortem organs, and cultured fibroblasts from patients with I-cell disease were resolved by ion exchange column chromatography. The elution pattern was compared in detail with that of the isozymes in control samples. This approach revealed no qualitative differences between the isozymes from the two sources. There is a relative increase of the neuraminidase-sensitive components of hexosaminidase in I-cell disease. This phenomenon is probably related less to the unknown primary defect of the disorder than to the quantitative change in the distribution of hexosaminidase components between the intra- and the extracellular compartment.

Arylsulphatases A and B in human diploid fibroblasts: differential assay with 4-methylumbelliferylsulphate and AgNO3.

A new technique is introduced for the differential assay of arylsulphatases A and B in centrifuged homogenates of cultured human skin fibroblasts, using 4-methylumbelliferyl-sulphate as a substrate and AgNO3 as a selective inhibitor of arylsulphatase A. The method can be applied in the diagnosis of metachromatic leucodystrophy, mucopolysaccharidosis type VI and mucosulphatidosis. Normal arylsulphatase activities were found in fibroblasts derived from patients with mucopolysaccharidoses types II, III-A and IV, known to be caused by deficiencies of various other sulphatases.

Akaline phosphatase: activity and variation in human diploid fibroblasts.

A method is introduced for the assay of alkaline phosphatase in homogenates of cultured human skin fibroblasts. In a first group of 11 strains, a four- to fifteen-fold increase of enzyme activity is consistently observed following a period of starvation. In the remaining 31 cell-strains similar specific activities of alkaline phosphatase are found irrespective of medium changes. In regularly fed cultures, an inverse exponential correlation between the specific activity of alkaline phosphatase and the age of the donor has been detected.

Human hyperargininemia: a mutation not expressed in skin fibroblasts?

Arginase specific activity in the fibroblasts from three hyperargininemia patients is similar to that in controls. Kinetic features, pH-optimum, effect of Mn++, apparent Km values and DEAE- and CM-cellulose chromatography isozymes are identical in either cell type. The arginase gene functional in fibroblasts may be unrelated to the cause of hyperargininemia in humans. The latter mutation may solely affect the arginase of erythrocytes.

Isoenzymes of serum N-acetyl-beta-D-glucosaminidase in the I cell disease heterozygote.

Serum N-acetyl-beta-D-hexosaminidase is compared quantitatively and qualitatively in 14 obligate heterozygotes for the mutant gene causing I cell disease (ICD) or mucolipidosis II and in 31 normal controls. The average specific activity in either group is significantly different but reliable heterozygote detection cannot be achieved because of some overlapping of the ranges of individual results. Fractionation of the enzyme either by DEAE cellulose column chromatography, or by heat inactivation, yields a typical average result for each genotype. Also, mere expression of the various components as percentages of the total activity is not useful for certain identification of the ICD heterozygote. There is considerable overlapping of the percents hexosaminidase I1 and A in both groups of sera. If enzymatic hydrolysis by any component is expressed as a partial activity, a much better though not absolute distinction between the ICD heterozygote and the normal control becomes possible. Only the latter way of expression of hexosaminidase results makes distinction between the ICD heterozygote and the Tay-Sachs heterozygote very probable.